SyncThink Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 16
Employees
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $163K
Latest Deal Amount
  • Investors
  • 7

SyncThink General Information

Description

Developer of a non-invasive eye-tracking technology designed to objectively assess visual impairments and brain health. The company's technology offers eye-tracking metrics using fully-integrated head-mounted eye-tracking devices for rapid and reliable assessment of attention focus and it uses virtual reality to assess abnormal eye movement, thereby enabling medical professionals to monitor and diagnose patients who have cognitive impairment or possible concussions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Other Devices and Supplies
Primary Office
  • 770 Washington Street
  • Suite 2A
  • Holliston, MA 01746
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SyncThink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - PPP 15-Apr-2020 $163K 00.000 Completed Generating Revenue
4. Later Stage VC (Series A1) 18-Jan-2018 00.000 00.000 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2018 00000 Completed Generating Revenue
2. Accelerator/Incubator 13-Dec-2016 $100K $100K Completed Generating Revenue
1. Grant 01-Jan-2012 $36M Completed Generating Revenue
To view SyncThink’s complete valuation and funding history, request access »

SyncThink Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A1 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view SyncThink’s complete cap table history, request access »

SyncThink Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a non-invasive eye-tracking technology designed to objectively assess visual impairments and brain health.
Diagnostic Equipment
Holliston, MA
16 As of 2021
00.000
000000000 - 00.000

00000000

e irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep
0000000000 000000000
New York, NY
0 As of 0000
000.00
00000000000 000.00

00000000

a aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000000000 000000000
Bethesda, MD
00 As of 0000
000.00
000 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SyncThink Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oculogica Venture Capital-Backed New York, NY 0 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Bethesda, MD 00 000.00 0000000000 0 000.00
000000 Formerly VC-backed Seraing, Belgium 0 00.000 000000&0 00.000
00000000 Venture Capital-Backed Bethesda, MD 00 000.00 000000000 - 000.00
To view SyncThink’s complete competitors history, request access »

SyncThink Patents

SyncThink Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210219838-A1 System and method for detection and quantification of impairment due to cannabis use Pending 21-Jan-2020 000000000
US-20160302713-A1 System and method for concussion detection and quantification Abandoned 15-Apr-2015 0000000000 0
US-20150208975-A1 System and method for target independent neuromotor analytics Abandoned 29-Jan-2014 00000000 00
US-9721476-B2 System and method for dynamic cognitive training Active 06-Nov-2013 00000000 0
US-20150126899-A1 System and method for dynamic cognitive training Granted 06-Nov-2013 G09B5/02 0
To view SyncThink’s complete patent history, request access »

SyncThink Executive Team (7)

Name Title Board Seat Contact Info
Kevin Quinn Interim Chief Executive Officer & Board Member
Scott Anderson Chief Clinical Officer
Jamshid Ghajar Ph.D Founder, Chairman & Chief Scientific Adviser
Coby Fleener Advisor
You’re viewing 4 of 7 executive team members. Get the full list »

SyncThink Board Members (7)

Name Representing Role Since
Alan Quasha JD Self Board Member 000 0000
Ernest Santin SyncThink Board Member 000 0000
Jamshid Ghajar Ph.D SyncThink Founder, Chairman & Chief Scientific Adviser 000 0000
John Van Merkensteijn III SyncThink Board Member 000 0000
Kevin Quinn SyncThink Interim Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

SyncThink Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SyncThink Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mitsubishi Chemical Advanced Materials Corporation Minority 000 0000 000000 0
Oceanic Partners Venture Capital Minority 000 0000 000000 0
StartUp Health Venture Capital Minority 000 0000 000000 0
Plug and Play Tech Center Accelerator/Incubator 000 0000 000000 0
MassChallenge Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »